Charles A. Krauth - Concepedia

Author

Charles A. Krauth

Southern Research Institute

Also Known As

C. A. KRAUTH, C. A. Krauth, CHARLES A. KRAUTH, Charles A. Krauth, Charles Krauth

Publications

548

Citations

H-Index

Concepts

All Affiliations

Southern Research Institute

About

Charles A. Krauth is an author at Southern Research Institute specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	208
2	Natural Sciences	4	4	81
3	Biochemistry	4	4	81
4	Engineering	1	1	22
5	Chemical Engineering	1	1	22

Charles A. Krauth

Publications

510

Citations

H-Index

Page 1

	Year	Citations
Imidazoles. I. Coupling Reactions of 5-Diazoimidazole-4-carboxamide<sup>1,2</sup> Y. Fulmer Shealy, Charles A. Krauth, John A. Montgomery The Journal of Organic Chemistry Molecular SciencesHeterocyclicAltmetric Attention ScoreChemometricsOrganic Chemistry	1962	139
Lipophilic Antifolates as Agents against Opportunistic Infections. 1. Agents Superior to Trimetrexate and Piritrexim against <i>Toxoplasma gondii</i> and <i>Pneumocystis carinii</i> in <i>in Vitro</i> Evaluations James R. Piper, Cheryl A. Johnson, Charles A. Krauth, Journal of Medicinal Chemistry	1996	47
Imidazoles. II. 5(or 4)-(Monosubstituted Triazeno)imidazole-4(or 5)-carboxamides<sup>1</sup> Y. Fulmer Shealy, Charles A. Krauth Journal of Medicinal Chemistry Medicinal ChemistryHeterocyclicMedicineAltmetric Attention ScoreOrganic Chemistry	1966	45
Complete Inhibition of Mouse Leukaemia L1210 by 5(or 4)-[3,3-Mbis (2-Chloroethyl)-l-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196) Y. Fulmer Shealy, Charles A. Krauth Nature Hematological MalignancyMedicinal ChemistryMouse Leukaemia L1210MedicineMalignant Blood Disorder	1966	42
A New Antifungal and Antibacterial Agent, Methyl 5(or 4)-(3,3-dimethyl-1-triazeno) imidazole-4(or 5)-carboxylate Y. Fulmer Shealy, Charles A. Krauth, Robert F. Pittillo, Journal of Pharmaceutical Sciences New AntifungalMedicinal ChemistryAntifungal AgentAntifungal AgentsMedicine	1967	32
Synthesis and Properties of the Antileukemic Agent 5(or 4)-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide Y. Fulmer Shealy, Charles A. Krauth, Lee B. Holum, Journal of Pharmaceutical Sciences Medicinal ChemistryHeterocyclicMedicineOrganic ChemistryHeterocycle Chemistry	1968	30
Synthesis of analogs of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea for evaluation as anticancer agents Thomas P. Johnston, G. S. MCCALEB, Sarah D. Clayton, Journal of Medicinal Chemistry	1977	30
2-Haloethylating agents for cancer chemotherapy. 2-Haloethyl sulfonates Y. Fulmer Shealy, Charles A. Krauth, Robert F. Struck, Journal of Medicinal Chemistry Antineoplastic ActivityHalogenationMedicinal ChemistryPharmaceutical ChemistryHeterocyclic	1983	24
Imidazoles V Y. Fulmer Shealy, Charles A. Krauth, S. J. CLAYTON, Journal of Pharmaceutical Sciences	1968	24
5‐[3‐(2‐chloroethyl)‐1‐triazenyl]imidazole‐4‐carboxamide and a Possible Mechanism of Action of 5‐[3,3‐Bis(2‐chloroethyl)‐1‐triazenyl]imidazole‐4‐carboxamide Y. Fulmer Shealy, C. Allen O’Dell, Charles A. Krauth Journal of Pharmaceutical Sciences Organic ChemistryPharmacologyPossible MechanismHeterocycle Chemistry	1975	24

Page 1